GSK and Theravance’s SUMMIT COPD CV Survival Study Fails to Achieve Primary Endpoint
COPD, News
GlaxoSmithKline and Theravance, Inc. have announced results from the Study to Understand Mortality and MorbidITy (SUMMIT) in chronic obstructive pulmonary disease (COPD). This was a Phase 3 clinical trial of ... Read more